Disclosure by Pfizer Sample Clauses

Disclosure by Pfizer. In the interest of transparency relating to its relationships with investigators and study sites or to ensure compliance with applicable local law, Pfizer may publicly disclose the support it provides under this Agreement. Such a disclosure by Pfizer may identify both the Institution and the Principal Investigator, but will clearly differentiate between payments or other transfers of value to institutions and those made to individuals. 2.2
AutoNDA by SimpleDocs
Disclosure by Pfizer. In the interest of transparency relating to its financial relationships with investigators and study sites or to ensure compliance with Applicable Law, industry codes and Pfizer policies, Pfizer may, and (in certain cases) is required to, report or otherwise disclose publicly payments or other transfer of value to certain health care providers, teaching hospitals and other health care organizations, including Funding provided under this Agreement. These laws and codes, and their implementing regulations, collectively are referred to as “Transparency Obligations.” Pfizer may disclose in any lawful manner the terms of this Agreement and any other information to the extent necessary for Pfizer to meet its Transparency Obligations. The terms of the Agreement shall be publicly disclosed on Pfizer’s webpage (xxx.xxxxxx.xx) when the Agreement is made and for a period of 2 years thereafter.
Disclosure by Pfizer. In the interest of transparency relating to its relationships with investigators and study sites or to ensure compliance with applicable local law, Pfizer may publicly disclose the support it provides under this Agreement. Such a disclosure by Pfizer may identify both the Institution and the Principal Investigator, but will clearly differentiate between payments or other transfers of value to institutions and those made to individuals. 2.2 Zverejnenie informácií zo strany spoločnosti Pfizer. V záujme transparentnosti ohľadom jej vzťahu so skúšajúcimi a pracoviskami klinického skúšania, alebo aby sa zabezpečilo dodržiavanie príslušných právnych predpisov môže spoločnosť Pfizer zverejniť podporu, ktorú poskytuje v rámci tejto zmluvy. Takéto zverejnenie informácií zo strany spoločnosti Pfizer môže identifikovať inštitúciu aj hlavného skúšajúceho, ale jasne rozlíši medzi platbami alebo inými prevodmi hodnôt 3.
Disclosure by Pfizer. In the interest of transparency relating to its financial relationships with investigators and study sites or to ensure compliance with Applicable Law, industry codes and Pfizer policies, Pfizer may report or otherwise publicly disclose payments or other transfers of value to certain health care providers or organizations, including the ISR Support. These laws, policies and codes, and their implementing regulations, are collectively “Transparency Obligations”. Pfizer may disclose in any lawful manner any information necessary for Pfizer to meet its Transparency Obligations. 3.7.1.
Disclosure by Pfizer. In the interest of transparency relating to its relationships with investigators and study sites or to ensure compliance with applicable local law, Pfizer may publicly disclose the support it provides under this Agreement. Such a disclosure by Pfizer may identify both the Health Services Provider and the Principal Investigator, but will clearly differentiate between payments or other transfers of value to legal persons and those made to individuals. Z veřejnění informací společností Pfizer. V zájmu transparence svých finančních vztahů se zkoušejícími a studijními pracovišti, nebo z důvodu zajištění dodržování příslušných místních právních předpisů, může společnost Pfizer zveřejnit finanční odměnu, kterou podle této Smlouvy poskytuje. Takové zveřejnění společností Pfizer může identifikovat jak Poskytovatele zdravotních služeb, tak i Hlavního zkoušejícího, ale bude zřetelně rozlišovat mezi platbami a jinými převody hodnot, jež jsou poukázány právnickým osobám, a těmi, jež jsou poukázány jednotlivcům.
Disclosure by Pfizer. In the interest of transparency relating to its financial relationships with investigators and Study/Registry sites or to ensure compliance with Applicable Law, industry codes and Pfizer policies, Pfizer may, and (in certain cases) is required to, report or otherwise disclose publicly payments or other transfer of value to certain health care providers, teaching hospitals and other health care organizations, including Funding provided under this Agreement. These laws and codes, and their implementing regulations, collectively are referred to as “Transparency Obligations.” Pfizer may disclose in any lawful manner the terms of this Agreement poskytovaných státem. 3.5 Žádné platby účtované třetím osobám. Příjemce grantu zajistí, aby žádnému subjektu studie, pojišťovně, orgánu veřejné moci ani jinému plátci ze strany třetích osob nebyly účtovány žádné platby za jakékoli činnosti související se Studií/Registrem prováděné Příjemcem grantu za použití Financování. 3.6
Disclosure by Pfizer. In the interest of transparency relating to its relationships with 2.2
AutoNDA by SimpleDocs
Disclosure by Pfizer. Subcontractor acknowledges that Pfizer is subject to laws related to the collection and reporting of any payments or transfers of value to certain healthcare professionals and teaching hospitals (hereinafter: the “Payments to Healthcare Professionals”), including those laws, industry codes and accompanying implementing regulations, including section 6002 of the Affordable Care Act and The European Federation of Pharmaceutical Industries and Associations (EFPIA) Code on Disclosure of Transfers of Value (hereinafter, collectively, the “Transparency Laws”). Pfizer may disclose in any lawful manner the terms of Master Agreement and SOW, the support that Pfizer is providing under it, and any other information to the extent necessary for Pfizer to meet its obligations under the Transparency Laws including certain identifying information of healthcare professionals including names, National Provider Identifier, licensure number(s), specialty, and addresses. Subcontractor will provide Penta and/or Pfizer with all information Pfizer needs to meet its obligations under any Transparency Laws including identifying healthcare professionals and teaching hospitals that receive a payment or transfer-of- value stemming from Pfizer’s support under the Master Agreement and SOW, as well as the amounts and dates of those payments or transfers-of-value. In accordance with EFPIA Disclosure Code and local country privacy and legal requirements, a signed consent document may be collected. Subcontractor will provide the information required under this paragraph by accurately completing a data report in a format reasonably determined by Pfizer.

Related to Disclosure by Pfizer

  • Radon Gas Disclosure Radon is a naturally occurring radioactive gas that, when it has accumulated in a building in sufficient quantities, may present health risks to persons who are exposed to it over time. Levels of radon that exceed federal and state guidelines have been found in buildings in Florida. Additional information regarding radon and radon testing may be obtained from your county public health unit.

  • Confidentiality and Disclosure of Offering Materials by Potential Investor Potential Investor acknowledges on behalf of itself and any and all Related Parties that the Offering Materials are considered confidential and proprietary information of Owner and/or HFF, and Potential Investor will not make (or cause or permit any Related Party to make) any Offering Materials available, or disclose any of the contents thereof, to any person without Owner’s or HFF’s prior written consent; provided, however, that the Offering Materials may be disclosed to the Potential Investor’s Representative (if any), the Potential Investor's partners, employees, legal counsel, advisors, institutional lenders and other capital sources (collectively the "Related Parties") as reasonably required for an evaluation of the Property. Such Related Parties shall be informed by Potential Investor of the confidential nature of the Offering Materials and the terms of this Agreement and shall be directed by Potential Investor to keep the Offering Materials and related information strictly confidential in accordance with this Agreement and to otherwise abide by the terms of this Agreement as if such party was the Potential Investor hereunder. In the event any Related Party shall take or omit to take any action which if taken or omitted to be taken by Potential Investor would constitute a breach of or a default under the terms hereof, the such act or omission by such Related Party shall be deemed to be a breach of the terms hereof by Potential Investor.

  • Confidentiality of Contractor Information The Contractor acknowledges and agrees that this Contract and any and all Contractor information obtained by the State in connection with this Contract are subject to the State of Vermont Access to Public Records Act, 1 V.S.A. § 315 et seq. The State will not disclose information for which a reasonable claim of exemption can be made pursuant to 1 V.S.A. § 317(c), including, but not limited to, trade secrets, proprietary information or financial information, including any formulae, plan, pattern, process, tool, mechanism, compound, procedure, production data, or compilation of information which is not patented, which is known only to the Contractor, and which gives the Contractor an opportunity to obtain business advantage over competitors who do not know it or use it. The State shall immediately notify Contractor of any request made under the Access to Public Records Act, or any request or demand by any court, governmental agency or other person asserting a demand or request for Contractor information. Contractor may, in its discretion, seek an appropriate protective order, or otherwise defend any right it may have to maintain the confidentiality of such information under applicable State law within three business days of the State’s receipt of any such request. Contractor agrees that it will not make any claim against the State if the State makes available to the public any information in accordance with the Access to Public Records Act or in response to a binding order from a court or governmental body or agency compelling its production. Contractor shall indemnify the State for any costs or expenses incurred by the State, including, but not limited to, attorneys’ fees awarded in accordance with 1 V.S.A. § 320, in connection with any action brought in connection with Contractor’s attempts to prevent or unreasonably delay public disclosure of Contractor’s information if a final decision of a court of competent jurisdiction determines that the State improperly withheld such information and that the improper withholding was based on Contractor’s attempts to prevent public disclosure of Contractor’s information. The State agrees that (a) it will use the Contractor information only as may be necessary in the course of performing duties, receiving services or exercising rights under this Contract; (b) it will provide at a minimum the same care to avoid disclosure or unauthorized use of Contractor information as it provides to protect its own similar confidential and proprietary information; (c) except as required by the Access to Records Act, it will not disclose such information orally or in writing to any third party unless that third party is subject to a written confidentiality agreement that contains restrictions and safeguards at least as restrictive as those contained in this Contract; (d) it will take all reasonable precautions to protect the Contractor’s information; and (e) it will not otherwise appropriate such information to its own use or to the use of any other person or entity. Contractor may affix an appropriate legend to Contractor information that is provided under this Contract to reflect the Contractor’s determination that any such information is a trade secret, proprietary information or financial information at time of delivery or disclosure.

Time is Money Join Law Insider Premium to draft better contracts faster.